LUPUZOR Trademark

Trademark Overview

On Friday, September 12, 2014, a trademark application was filed for LUPUZOR with the United States Patent and Trademark Office. The USPTO has given the LUPUZOR trademark a serial number of 86393379. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 7, 2018. This trademark is owned by Immupharma AG. The LUPUZOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of immunological disorders
lupuzor

General Information

Serial Number86393379
Word MarkLUPUZOR
Filing DateFriday, September 12, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 7, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 3, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of immunological disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 19, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameImmupharma AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressReinach CH-4153
CH
Party NameImmupharma AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressReinach CH-4153
CH

Trademark Events

Event DateEvent Description
Monday, May 7, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 7, 2018ABANDONMENT - NO USE STATEMENT FILED
Saturday, September 30, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 29, 2017EXTENSION 5 GRANTED
Monday, September 25, 2017EXTENSION 5 FILED
Monday, September 25, 2017TEAS EXTENSION RECEIVED
Tuesday, April 4, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 31, 2017EXTENSION 4 GRANTED
Friday, March 31, 2017EXTENSION 4 FILED
Friday, March 31, 2017TEAS EXTENSION RECEIVED
Friday, October 7, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 6, 2016EXTENSION 3 GRANTED
Thursday, September 29, 2016EXTENSION 3 FILED
Thursday, September 29, 2016TEAS EXTENSION RECEIVED
Wednesday, May 4, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 3, 2016EXTENSION 2 GRANTED
Wednesday, March 30, 2016EXTENSION 2 FILED
Monday, May 2, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 30, 2016TEAS EXTENSION RECEIVED
Friday, January 22, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 2, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 30, 2015EXTENSION 1 GRANTED
Wednesday, September 30, 2015EXTENSION 1 FILED
Wednesday, September 30, 2015TEAS EXTENSION RECEIVED
Tuesday, March 31, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 3, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 3, 2015PUBLISHED FOR OPPOSITION
Wednesday, January 14, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 26, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 26, 2014ASSIGNED TO EXAMINER
Friday, September 19, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 16, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

lupuzor disorders immunological treatment preparations pharmaceutical